David Watson serves as the General Counsel at Apellis Pharmaceuticals Inc., a biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory diseases. In his role, Watson is responsible for overseeing all legal matters, including corporate governance, intellectual property, and compliance. His strategic guidance has been instrumental in navigating the complex regulatory landscape and ensuring that Apellis remains at the forefront of the industry. Before joining Apellis, Watson had an illustrious career in the legal field, with over two decades of experience in the life sciences sector. He previously held the position of Senior Vice President and General Counsel at a leading biotechnology firm, where he played a key role in several high-profile mergers and acquisitions that significantly expanded the company's portfolio and market presence. Watson's expertise in intellectual property law has been particularly valuable, as he has successfully secured numerous patents for groundbreaking therapies, thereby strengthening the company's competitive edge. Watson's achievements extend beyond his corporate roles, as he is also an active member of several professional organizations dedicated to advancing the life sciences industry. He frequently speaks at industry conferences, sharing insights on the legal challenges and opportunities facing biopharmaceutical companies. At Apellis, Watson's leadership has fostered a culture of integrity and innovation, positioning the company for continued success in developing life-changing treatments for patients worldwide.